Communications Biology · 2020 · 26 citations · 34 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyBlood-brain Barrier BiologyBlood-brain Barrier DeliveryBlood-brain Barrier PharmacologyGlutamatergic NeurochemistryNeuroprotectionStrokeBlood-brain Barrier ProtectionCerebral Ischemia NeuroprotectionGlutamate MetabolismIschemic Neuronal DeathIschemic Stroke PathophysiologyRodent Cerebral IschemiaStroke NeuroprotectionTransaminase Catalysis
Stroke is a major cause of morbidity, mortality, and disability. During ischemic stroke, a marked and prolonged rise of glutamate concentration in the brain causes neuronal cell death. This study explores the protective effect of a bioconjugate form of glutamate oxaloacetate transaminase (hrGOT), which catalyzes the depletion of blood glutamate in the bloodstream for ~6 days following a single administration. When treated with this bioconjugate, a significant reduction of the infarct volume and a better retention of sensorimotor function was observed for ischemic rats compared to those treated with saline. Moreover, the equivalent dose of native hrGOT yielded similar results to the saline treated group for some tests. Targeting the bioconjugate to the blood-brain-barrier did not improve its performance. The data suggest that the bioconjugates draw glutamate out of the brain by displacing homeostasis between the different glutamate pools of the body.
34
Preventing stroke: saving lives around the world
Kathleen Strong, Colin Mathers, Ruth Bonita · The Lancet Neurology · 2007 · 1.5K citations
Functional assessments in mice and rats after focal stroke
A. Jacqueline Hunter, Joseph D. Hatcher, David Virley et al. · Neuropharmacology · 2000 · 296 citations
Cognitive Deficits After Focal Cerebral Ischemia in Mice
Kimihiko Hattori, Hanna Lee, Patricia D. Hurn et al. · Stroke · 2000 · 201 citations · Full text
Medicine, Neurology, Neuroscience +17